Transfusion Medicine

Papers
(The TQCC of Transfusion Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels52
Impact of COVID‐19 in the attendance of blood donors and production on a Brazilian Blood Centres18
Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease15
Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection14
Comparison of four methods to measure haemoglobin concentrations in whole blood donors (COMPARE): A diagnostic accuracy study13
Practical approach to transfusion management of post‐partum haemorrhage12
Convalescent plasma for COVID‐19: Back to the future11
Absence of SARS‐CoV‐2 viraemia in a blood donor with COVID‐19 post‐donation11
Impact of severe acute respiratory syndrome on blood services and blood in Hong Kong in 200311
Erythropoiesis‐stimulating agents as replacement therapy for blood transfusions in critically ill patients with anaemia: A systematic review with meta‐analysis11
Machine learning for predicting preoperative red blood cell demand11
Trust and distrust: Identifying recruitment targets for ethnic minority blood donors11
Effect of leukoreduction on transfusion‐related immunomodulation in patients undergoing cardiac surgery11
Systematic review and meta‐analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID‐19): Evidence‐10
Motivators of and barriers to becoming a COVID‐19 convalescent plasma donor: A survey study10
Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective10
Hydrops fetalis associated with anti‐CD36 antibodies in fetal and neonatal alloimmune thrombocytopenia: Possible underlying mechanism10
Adherence to blood product transfusion guidelines—An observational study of the current transfusion practice in a medical intensive care unit9
Massive transfusion protocols in paediatric trauma population: A systematic review9
The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti‐D prophylaxis8
E‐learning/online education in transfusion medicine: A cross‐sectional international survey8
Evaluating the risk of transfusion and transplant‐transmitted monkeypox infections8
Risk of hepatitis‐E virus infections among blood donors in a regional blood transfusion centre in western India8
Inter‐donor variability in deformability of red blood cells in blood units8
A review of whole‐blood donors' willingness, motives, barriers and interventions related to donating another substance of human origin8
Effect of the first year of COVID‐19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system7
Convalescent plasma and COVID‐19: Time for a second—second look?7
Safety and efficacy of COVID‐19 convalescent plasma in severe pulmonary disease: A report of 17 patients7
Beyond COVID‐19 and lessons learned in the United States7
Deterrents in recruitment of COVID‐19 convalescent plasma donors: Experience from a hospital‐based blood centre in India7
Transfusion in critical care: Past, present and future6
Effect of patient blood management system and feedback programme on appropriateness of transfusion: An experience of Asia's first Bloodless Medicine Center on a hospital basis6
Pulmonary complications of transfusion: Changes, challenges, and future directions6
Prophylactic tranexamic acid use in non‐cardiac surgeries at high risk for transfusion6
Fertility and pregnancy in Iranian thalassemia patients: An update on transfusion complications6
Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction6
A UK national survey of prophylactic platelet transfusion thresholds in non‐bleeding, critically ill adults6
Association between the length of storage of transfused leukoreduced red blood cell units and hospital‐acquired infections in critically ill children: A secondary analysis of the TRIPICU st6
Development and validation of a nomogram to predict intraoperative blood transfusion for gastric cancer surgery6
Salvage of refractory post‐transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab5
Assessment the knowledge of blood transfusion in Iranian nurses of Tehran's hospitals5
Extended red blood cell matching for all transfusion recipients is feasible5
Alloimmunisation rate of patients on Daratumumab: A retrospective cohort study of patients in England5
Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England5
Transfusion therapy of neonatal and paediatric patients: They are not just little adults5
Monitoring iron stores in Icelandic blood donors from 1997 through 20195
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach5
Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt‐Jakob disease: The SaBTO review5
Comparison of ABO antibody titration, IgG subclasses and qualitative haemolysin test to reduce the risk of passive haemolysis associated with platelet transfusion5
Role of ABO blood system in COVID‐19: Findings from a southern Italian study4
Probable cefepime‐induced immune mediated hemolytic anaemia4
Histo‐blood group A is a risk factor for severe COVID‐194
Convalescent plasma for COVID‐19: Donor demographic factors associated high neutralising antibody titres4
ABO‐incompatible convalescent plasma transfusion: Yes, you can4
Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England4
Impact of Covid‐19 epidemic on the activities of a blood centre, transfusion support for infected patients and clinical outcomes4
Skin flora and bacterial contamination of diversion pouch and recovered platelet components in Moroccan blood donors4
The haemoglobinopathy survey: The reality of transfusion practice in sickle cell disease and thalassaemia in England4
Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China4
Recovery of platelet‐rich red blood cells and acquisition of convalescent plasma with a novel gravity‐driven blood separation device4
Red blood cell transfusion in myelodysplastic syndromes: A systematic review4
Passenger lymphocyte syndrome with severe haemolysis misdiagnosed/treated as cold agglutinin syndrome: Analysis of case and diagnostic error4
Improving blood‐prescribing decisions: Evaluating the efficacy of a blood guidelines app4
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation4
Sickle cell disease patients in two London trusts: Genotyping including RH variants4
Screening of at‐risk blood donors for Chagas disease in non‐endemic countries: Lessons from a 2‐year experience in Tuscany, Italy3
Utility of pre‐operative haemoglobin concentration to guide peri‐operative blood tests for hip and knee arthroplasty: A decision curve analysis3
Poster session3
London 2017: Lessons learned in transfusion emergency planning3
The contribution and potential of older blood donors in Asia Pacific regions3
A physiology‐based trigger score to guide perioperative transfusion of allogeneic red blood cells: A multicentre randomised controlled trial3
The use of prothrombin complex concentrate in chronic liver disease: A review of the literature3
The lack of anti‐PF4 antibodies in convalescent plasma from COVID‐19 infected blood donor3
Patterns of paediatric massive blood transfusion protocol use in trauma and non‐trauma patients3
Prospective audit of blood transfusion request forms and continuing medical education to optimise compliance of clinicians in a hospital setting3
Impact of microbial contamination of haematopoietic stem cells on post‐transplant outcomes: A retrospective study from tertiary care centre in India3
Emergency response to COVID‐19 epidemic: One Chinese blood centre's experience3
Kinetics of anti‐SARS‐COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability3
Transfusion requirement prediction score for patients undergoing cardiac surgery: An experience from a tertiary care set‐up from South India3
Pain control and functional improvement in patients treated by autologous conditioned serum after failure of platelet rich plasma treatments in knee osteoarthritis3
Confirmed non‐invasive prenatal testing for foetal Rh blood group genotyping along with bi‐allelic short insertion/deletion polymorphisms as a positive internal control3
Blood group P1 prediction using multiplex PCR genotyping of A4GALT among Thai blood donors3
Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa3
Splanchnic‐cerebral oxygenation ratio associated with packed red blood cell transfusion in preterm infants2
Implementation of high‐throughput non‐invasive prenatal testing for fetal RHD genotype testing in England: Results of a cross‐sectional survey of maternity units and expert interview2
Rh deficiency syndrome with anti Rh‐29 in a multiparous lady causing transfusion reactions2
Serological screening and genetic analysis ofRhCEvariants in the Chinese Southern Han donors2
Detection and analysis of blood donors seropositive for syphilis2
Parvovirus B19 and recipient safety: is it time to do more?2
Effects of storage on quality and function of acid‐treated platelets with reduced HLA Class I surface expression2
Higher levels of von Willebrand factor in hospitalised patient plasma provides an explanation for the association of ABO blood group and secretor status with COVID19 severity2
Effects of cryopreservation on gram‐positive bacteria contaminants in umbilical cord blood2
A survey of nurses to assess transfusion practice at the bedside using an electronic identification system: Experience at a university hospital2
Paroxysmal cold hemoglobinuria: A diagnostic dilemma in a paediatric patient2
Motivations for blood donation by HIV‐positive individuals on antiretrovirals in South Africa: A qualitative study2
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia2
Divergence in phenotyping and genotyping analysis of the Lewis histo‐blood group system2
Anaphylactic reaction after pre‐deposit autologous blood transfusion2
Blood collection failures from a blood establishment perspective2
Prevalence of leucocyte antibodies in non‐transfused male and female platelet apheresis donors2
HLA‐DRB1 and cytokine polymorphisms in Brazilian patients with myelodysplastic syndromes and its association with red blood cell alloimmunization2
Re‐examine the transfusion transmitted risk of SARS‐CoV‐2 virus during a major COVID‐19 outbreak in 20222
Validation of an apoptosis assay for extracorporeal photopheresis2
Implementation of an anaemia walk‐in clinic: Feasibility and preliminary data from the Orthopedic University Hospital2
BGvar: A comprehensive resource for blood group immunogenetics2
Role of donor self‐reporting in securing blood safety during COVID‐19 pandemic2
Demographic, clinical, and biochemical predictors of pica in high‐intensity blood donors2
D variants in the population of D‐negative blood donors in the north‐eastern region of Croatia2
A prospective interventional study to assess the impact of a ‘structured compact training’ on knowledge and skills of safe blood transfusion practices among nurses working in a tertiary care institute2
Anti‐HBc and hepatitis B virus DNA among HBsAg‐negative blood donors from the main central blood bank units in Eastern Libya2
Prevalence of anaemia in patients discharged from the paediatric intensive care unit2
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis2
The central blood volume as measured by thoracic electrical impedance and plasma proANP is not compromised by donation of 900 mL of blood in men2
Life in times of COVID‐192
Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T‐cell leukaemia virus type‐1 and type‐2 infection in a London teaching hospital with a large solid organ transplant centre2
Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia2
A case of hyperhaemolysis syndrome in a pregnant Chinese woman with β‐thalassemia during perinatal transfusion2
Low‐titer group O whole blood in military ground ambulances: Lessons from the Israel Defense Forces initial experience2
ABO(H) and Lewis blood group substances and disease treatment2
Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia2
0.036020994186401